129 related articles for article (PubMed ID: 33929528)
41. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
Wong AK; Chan RC; Nichols WS; Bose S
Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
[TBL] [Abstract][Full Text] [Related]
42. Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
Tracht JM; Davis AD; Fasciano DN; Eltoum IA
Cancer Cytopathol; 2017 Oct; 125(10):795-805. PubMed ID: 28817235
[TBL] [Abstract][Full Text] [Related]
43. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire.
Crothers BA; Darragh TM; Tambouret RH; Nayar R; Barkan GA; Zhao C; Booth CN; Padmanabhan V; Tabatabai ZL; Souers RJ; Thomas N; Wilbur DC; Moriarty AT
Arch Pathol Lab Med; 2016 Jan; 140(1):13-21. PubMed ID: 26046490
[TBL] [Abstract][Full Text] [Related]
44. High-risk human papillomavirus DNA test results are useful for disease risk stratification in women with unsatisfactory liquid-based cytology pap test results.
Zhao C; Austin RM
J Low Genit Tract Dis; 2009 Apr; 13(2):79-84. PubMed ID: 19387127
[TBL] [Abstract][Full Text] [Related]
45. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
[TBL] [Abstract][Full Text] [Related]
46. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
[TBL] [Abstract][Full Text] [Related]
47. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
Guo M; Shlyakhova N; Khanna A; Tinnirello AA; Schmeler KM; Hwang J; Sturgis EM; Stewart J
J Am Soc Cytopathol; 2021; 10(4):399-405. PubMed ID: 33967024
[TBL] [Abstract][Full Text] [Related]
48. Correlation of Pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system.
Nuovo GJ; Bartholomew D; Jung WW; Han IK; Um T; Grabarz DF; Lee DJ; McCabe RT
Diagn Mol Pathol; 2008 Jun; 17(2):107-11. PubMed ID: 18382353
[TBL] [Abstract][Full Text] [Related]
49. Utility of the in situ detection of HPV in Pap smears diagnosed as within normal limits.
Menezes G; Euscher E; Schwartz B; Catania F; Chancellor J; Nuovo GJ
Acta Cytol; 2001; 45(6):919-26. PubMed ID: 11726118
[TBL] [Abstract][Full Text] [Related]
50. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
51. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
[TBL] [Abstract][Full Text] [Related]
52. Does the interval between papanicolaou tests influence the quality of cytology?
Jeronimo J; Khan MJ; Schiffman M; Solomon D;
Cancer; 2005 Jun; 105(3):133-8. PubMed ID: 15822121
[TBL] [Abstract][Full Text] [Related]
53. Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia.
Kussaibi H; Al Dossary R; Ahmed A; Muammar A; Aljohani R
Acta Cytol; 2021; 65(1):48-55. PubMed ID: 32784299
[TBL] [Abstract][Full Text] [Related]
54. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
55. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
[TBL] [Abstract][Full Text] [Related]
56. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
Levi AW; Kelly DP; Rosenthal DL; Ronnett BM
Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979
[TBL] [Abstract][Full Text] [Related]
57. Human Papillomavirus Genotyping among Different Cervical Smears in Duhok/Iraq.
Pity IS; Abdo HM; Goreal AA
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2059-2064. PubMed ID: 31350966
[TBL] [Abstract][Full Text] [Related]
58. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
[TBL] [Abstract][Full Text] [Related]
59. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
60. Detection of human papillomavirus on Papanicolaou-stained cervical smears using indirect in situ polymerase chain reaction hybridization.
Manavi M; Bauer M; Pischinger K; Czerwenka K
Arch Pathol Lab Med; 2001 Mar; 125(3):353-7. PubMed ID: 11231482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
